Want to see HCA full AI Analyst Report?

HCA Healthcare (HCA) Stock Forecast & Price Target

1,827 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HCA Analyst Ratings

Moderate Buy

12 Buy

7 Hold

1 Sell

Based on 20 analysts giving stock ratings to

HCA

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HCA Stock 12 Month Forecast

Average Price Target

$452.00

▲(5.42% Upside)

Based on 20 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $452.00 with a high forecast of $579.00 and a low forecast of $380.00. The average price target represents a 5.42% change from the last price of $428.76.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"369":"$369","580":"$580","421.75":"$421.8","474.5":"$474.5","527.25":"$527.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":579,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$579.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":452,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$452.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":380,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$380.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[369,421.75,474.5,527.25,580],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,413.58,426.3046153846154,439.02923076923076,451.75384615384615,464.47846153846154,477.20307692307694,489.92769230769227,502.65230769230766,515.376923076923,528.1015384615384,540.8261538461538,553.5507692307692,566.2753846153846,{"y":579,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,413.58,416.5353846153846,419.4907692307692,422.44615384615383,425.40153846153845,428.35692307692307,431.3123076923077,434.2676923076923,437.2230769230769,440.17846153846153,443.13384615384615,446.08923076923077,449.0446153846154,{"y":452,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,413.58,410.99692307692305,408.4138461538461,405.8307692307692,403.2476923076923,400.6646153846154,398.08153846153846,395.4984615384615,392.9153846153846,390.33230769230767,387.7492307692308,385.16615384615386,382.58307692307693,{"y":380,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":401.237,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":423.955,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":457.398,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":500.503,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":465.234,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":495.119,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":531.064,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":473.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":432.223,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":370.218,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":393.24,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":402.59,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":413.58,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$579.00

Average Price Target$452.00

Lowest Price Target$380.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Lance Wilkes

Bernstein

$426

Hold

-0.64%

Downside

Reiterated

09/04/26

Bernstein Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Ben Hendrix

RBC Capital

$435

Buy

1.46%

Upside

Reiterated

09/01/26

Analysts Offer Insights on NA Companies: SpaceX (NASDAQ: SPCX) and HCA Healthcare (NYSE: HCA)

Benjamin Rossi

J.P. Morgan

$425

Hold

-0.88%

Downside

Reiterated

08/24/26

J.P. Morgan Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Kevin Fischbeck

Bank of America Securities

$400→$425

Hold

-0.88%

Downside

Reiterated

08/10/26

HCA Healthcare (HCA) Receives a Hold from Bank of America Securities

David Toung

Argus Research

$500

Buy

16.62%

Upside

Assigned

08/07/26

Argus Research Sticks to Its Buy Rating for HCA Healthcare (HCA)

David S Macdonald

Truist Financial

$495

Buy

15.45%

Upside

Reiterated

08/05/26

Truist Financial Sticks to Its Buy Rating for HCA Healthcare (HCA)

Stephen Baxter

Wells Fargo

$369→$381

Hold

-11.14%

Downside

Assigned

08/03/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: AptarGroup (NYSE: ATR), Myriad Genetics (NASDAQ: MYGN) and HCA Healthcare (NYSE: HCA)

Ann Hynes

Mizuho Securities

$525→$475

Buy

10.78%

Upside

Reiterated

07/28/26

HCA Healthcare price target lowered to $475 from $525 at MizuhoHCA Healthcare price target lowered to $475 from $525 at Mizuho

Brian Tanquilut

Jefferies

$450

Buy

4.95%

Upside

Reiterated

07/28/26

Jefferies Remains a Buy on HCA Healthcare (HCA)

Michael Wiederhorn

Oppenheimer

$520→$485

Buy

13.12%

Upside

Reiterated

07/27/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

A.J. Rice

UBS

$635→$579

Buy

35.04%

Upside

Reiterated

07/27/26

HCA Healthcare price target lowered to $579 from $635 at UBSHCA Healthcare price target lowered to $579 from $635 at UBS

Craig Hettenbach

Morgan Stanley

$425→$380

Sell

-11.37%

Downside

Reiterated

07/27/26

HCA Healthcare price target lowered to $380 from $425 at Morgan StanleyHCA Healthcare price target lowered to $380 from $425 at Morgan Stanley

Pito Chickering

Deutsche Bank

$540→$476

Buy

11.02%

Upside

Assigned

07/27/26

HCA Healthcare price target lowered to $476 from $540 at Deutsche BankHCA Healthcare price target lowered to $476 from $540 at Deutsche Bank

Scott Fidel

Goldman Sachs

$558→$485

Buy

13.12%

Upside

Reiterated

07/27/26

HCA Healthcare price target lowered to $485 from $558 at Goldman SachsHCA Healthcare price target lowered to $485 from $558 at Goldman Sachs

Matthew Gillmor CFA

KeyBanc

$475→$435

Buy

1.46%

Upside

Reiterated

07/27/26

Analysts Conflicted on These Healthcare Names: HCA Healthcare (NYSE: HCA), Summit Therapeutics (NASDAQ: SMMT) and Neuphoria Therapeutics (NASDAQ: NEUP)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Lance Wilkes

Bernstein

$426

Hold

-0.64%

Downside

Reiterated

09/04/26

Bernstein Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Ben Hendrix

RBC Capital

$435

Buy

1.46%

Upside

Reiterated

09/01/26

Analysts Offer Insights on NA Companies: SpaceX (NASDAQ: SPCX) and HCA Healthcare (NYSE: HCA)

Benjamin Rossi

J.P. Morgan

$425

Hold

-0.88%

Downside

Reiterated

08/24/26

J.P. Morgan Reaffirms Their Hold Rating on HCA Healthcare (HCA)

Kevin Fischbeck

Bank of America Securities

$400→$425

Hold

-0.88%

Downside

Reiterated

08/10/26

HCA Healthcare (HCA) Receives a Hold from Bank of America Securities

David Toung

Argus Research

$500

Buy

16.62%

Upside

Assigned

08/07/26

Argus Research Sticks to Its Buy Rating for HCA Healthcare (HCA)

David S Macdonald

Truist Financial

$495

Buy

15.45%

Upside

Reiterated

08/05/26

Truist Financial Sticks to Its Buy Rating for HCA Healthcare (HCA)

Stephen Baxter

Wells Fargo

$369→$381

Hold

-11.14%

Downside

Assigned

08/03/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: AptarGroup (NYSE: ATR), Myriad Genetics (NASDAQ: MYGN) and HCA Healthcare (NYSE: HCA)

Ann Hynes

Mizuho Securities

$525→$475

Buy

10.78%

Upside

Reiterated

07/28/26

HCA Healthcare price target lowered to $475 from $525 at MizuhoHCA Healthcare price target lowered to $475 from $525 at Mizuho

Brian Tanquilut

Jefferies

$450

Buy

4.95%

Upside

Reiterated

07/28/26

Jefferies Remains a Buy on HCA Healthcare (HCA)

Michael Wiederhorn

Oppenheimer

$520→$485

Buy

13.12%

Upside

Reiterated

07/27/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

A.J. Rice

UBS

$635→$579

Buy

35.04%

Upside

Reiterated

07/27/26

HCA Healthcare price target lowered to $579 from $635 at UBSHCA Healthcare price target lowered to $579 from $635 at UBS

Craig Hettenbach

Morgan Stanley

$425→$380

Sell

-11.37%

Downside

Reiterated

07/27/26

HCA Healthcare price target lowered to $380 from $425 at Morgan StanleyHCA Healthcare price target lowered to $380 from $425 at Morgan Stanley

Pito Chickering

Deutsche Bank

$540→$476

Buy

11.02%

Upside

Assigned

07/27/26

HCA Healthcare price target lowered to $476 from $540 at Deutsche BankHCA Healthcare price target lowered to $476 from $540 at Deutsche Bank

Scott Fidel

Goldman Sachs

$558→$485

Buy

13.12%

Upside

Reiterated

07/27/26

HCA Healthcare price target lowered to $485 from $558 at Goldman SachsHCA Healthcare price target lowered to $485 from $558 at Goldman Sachs

Matthew Gillmor CFA

KeyBanc

$475→$435

Buy

1.46%

Upside

Reiterated

07/27/26

Analysts Conflicted on These Healthcare Names: HCA Healthcare (NYSE: HCA), Summit Therapeutics (NASDAQ: SMMT) and Neuphoria Therapeutics (NASDAQ: NEUP)

Stocks with the Highest Top Analyst Consensus in the General Sector

STDNStandard Nuclear

SKHYSK Hynix

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

3 Months

Michael WiederhornOppenheimer

Success Rate

25/36 ratings generated profit

Average Return

+7.10%

Copying Michael Wiederhorn's trades and holding each position for 3 Months would result in 69.44% of your transactions generating a profit, with an average return of +7.10% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

25/28 ratings generated profit

Average Return

+18.49%

Copying Scott Fidel's trades and holding each position for 1 Year would result in 89.29% of your transactions generating a profit, with an average return of +18.49% per trade.

2 Years

Whit MayoLeerink Partners

Success Rate

45/46 ratings generated profit

Average Return

+51.23%

Copying Whit Mayo's trades and holding each position for 2 Years would result in 97.83% of your transactions generating a profit, with an average return of +51.23% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HCA Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HCA has received 23 Buy Ratings, 17 Hold Ratings, and 2 Sell Ratings. HCA average Analyst price target in the past 3 months is 452.00.

Each month's total comprises the sum of three months' worth of ratings.

HCA Financial Forecast

HCA Earnings Forecast

Next quarter’s earnings estimate for HCA is $6.71 with a range of $5.83 to $7.35. The previous quarter’s EPS was $7.59. HCA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.

HCA Sales Forecast

Next quarter’s sales forecast for HCA is $19.35B with a range of $18.80B to $19.87B. The previous quarter’s sales results were $20.23B. HCA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year HCA has Performed in-line its overall industry.

HCA Stock Forecast FAQ

What is HCA’s average 12-month price target, according to analysts?

Based on analyst ratings, HCA Healthcare’s 12-month average price target is 452.00.

What is HCA’s upside potential, based on the analysts’ average price target?

HCA Healthcare has 5.42% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HCA a Buy, Sell or Hold?

HCA Healthcare has a consensus rating of Moderate Buy which is based on 12 buy ratings, 7 hold ratings and 1 sell ratings.

What is HCA Healthcare’s price target?

The average price target for HCA Healthcare is 452.00. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $579.00 ,the lowest forecast is $380.00. The average price target represents 5.42% Increase from the current price of $428.76.

What do analysts say about HCA Healthcare?

HCA Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.

How can I buy shares of HCA?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Analyst Ratings

HCA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering HCA Healthcare

HCA Analyst Recommendation Trends

HCA Financial Forecast

HCA Earnings Forecast

HCA Sales Forecast

HCA Stock Forecast FAQ

Detailed List of Analyst Forecasts